chr20-57562128-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_002591.4(PCK1):​c.282C>T​(p.Ile94Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.189 in 1,613,658 control chromosomes in the GnomAD database, including 30,555 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2424 hom., cov: 33)
Exomes 𝑓: 0.19 ( 28131 hom. )

Consequence

PCK1
NM_002591.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.472

Publications

26 publications found
Variant links:
Genes affected
PCK1 (HGNC:8724): (phosphoenolpyruvate carboxykinase 1) This gene is a main control point for the regulation of gluconeogenesis. The cytosolic enzyme encoded by this gene, along with GTP, catalyzes the formation of phosphoenolpyruvate from oxaloacetate, with the release of carbon dioxide and GDP. The expression of this gene can be regulated by insulin, glucocorticoids, glucagon, cAMP, and diet. Defects in this gene are a cause of cytosolic phosphoenolpyruvate carboxykinase deficiency. A mitochondrial isozyme of the encoded protein also has been characterized. [provided by RefSeq, Jul 2008]
PCK1 Gene-Disease associations (from GenCC):
  • phosphoenolpyruvate carboxykinase deficiency, cytosolic
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • phosphoenolpyruvate carboxykinase deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 20-57562128-C-T is Benign according to our data. Variant chr20-57562128-C-T is described in ClinVar as Benign. ClinVar VariationId is 338874.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.472 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.206 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCK1NM_002591.4 linkc.282C>T p.Ile94Ile synonymous_variant Exon 3 of 10 ENST00000319441.6 NP_002582.3 P35558-1
PCK1XM_024451888.2 linkc.10+493C>T intron_variant Intron 2 of 8 XP_024307656.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCK1ENST00000319441.6 linkc.282C>T p.Ile94Ile synonymous_variant Exon 3 of 10 1 NM_002591.4 ENSP00000319814.4 P35558-1
PCK1ENST00000467047.1 linkn.1049C>T non_coding_transcript_exon_variant Exon 1 of 2 1
PCK1ENST00000475833.1 linkn.858C>T non_coding_transcript_exon_variant Exon 2 of 2 2
PCK1ENST00000498194.1 linkn.-220C>T upstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.171
AC:
26059
AN:
152038
Hom.:
2416
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.129
Gnomad AMI
AF:
0.238
Gnomad AMR
AF:
0.144
Gnomad ASJ
AF:
0.170
Gnomad EAS
AF:
0.0112
Gnomad SAS
AF:
0.153
Gnomad FIN
AF:
0.219
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.209
Gnomad OTH
AF:
0.157
GnomAD2 exomes
AF:
0.172
AC:
43260
AN:
251326
AF XY:
0.176
show subpopulations
Gnomad AFR exome
AF:
0.125
Gnomad AMR exome
AF:
0.132
Gnomad ASJ exome
AF:
0.170
Gnomad EAS exome
AF:
0.00794
Gnomad FIN exome
AF:
0.222
Gnomad NFE exome
AF:
0.208
Gnomad OTH exome
AF:
0.185
GnomAD4 exome
AF:
0.191
AC:
279285
AN:
1461502
Hom.:
28131
Cov.:
33
AF XY:
0.192
AC XY:
139361
AN XY:
727064
show subpopulations
African (AFR)
AF:
0.126
AC:
4221
AN:
33478
American (AMR)
AF:
0.129
AC:
5775
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.173
AC:
4531
AN:
26136
East Asian (EAS)
AF:
0.00509
AC:
202
AN:
39700
South Asian (SAS)
AF:
0.171
AC:
14770
AN:
86250
European-Finnish (FIN)
AF:
0.223
AC:
11936
AN:
53414
Middle Eastern (MID)
AF:
0.153
AC:
884
AN:
5768
European-Non Finnish (NFE)
AF:
0.204
AC:
226495
AN:
1111656
Other (OTH)
AF:
0.173
AC:
10471
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
11611
23222
34834
46445
58056
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7652
15304
22956
30608
38260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.172
AC:
26099
AN:
152156
Hom.:
2424
Cov.:
33
AF XY:
0.170
AC XY:
12649
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.130
AC:
5388
AN:
41498
American (AMR)
AF:
0.144
AC:
2195
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.170
AC:
591
AN:
3468
East Asian (EAS)
AF:
0.0112
AC:
58
AN:
5186
South Asian (SAS)
AF:
0.154
AC:
746
AN:
4830
European-Finnish (FIN)
AF:
0.219
AC:
2317
AN:
10580
Middle Eastern (MID)
AF:
0.150
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
0.209
AC:
14213
AN:
67986
Other (OTH)
AF:
0.156
AC:
330
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1112
2225
3337
4450
5562
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.191
Hom.:
9502
Bravo
AF:
0.160
Asia WGS
AF:
0.0800
AC:
281
AN:
3478
EpiCase
AF:
0.202
EpiControl
AF:
0.199

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Phosphoenolpyruvate carboxykinase deficiency, cytosolic Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
15
DANN
Benign
0.76
PhyloP100
0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6070157; hg19: chr20-56137184; COSMIC: COSV108117465; COSMIC: COSV108117465; API